Anuh Pharma Ltd

NSE: ANUHPHR · BSE: 506260 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹90.42
Market cap: ₹906.2 Cr
Revenue (annual): ₹771.7 Cr
Net profit (annual): ₹41.05 Cr
P/E (TTM): 20.5×Sector 50.4×
Promoter holding: 71.80%+0.00% QoQ
FII holding: 0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Earnings Call 2 Legal & Regulatory 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

19 Aug 2026 16:46 IST BSE

Earnings Call

Anuh Pharma Investor Presentation: Key Takeaways

Anuh Pharma reported strong Q1 FY27 results with 4% YoY revenue growth and 38% PAT growth, driven by a shift to high-value regulated markets.

Call: Guides 18% growth

Open call summary → Read the filing ↗

28 May 2026 17:24 IST BSE

Earnings Call

Anuh Pharma Earnings Call: Key Takeaways

Anuh Pharma reported FY26 revenue growth of 15.66% YoY to ₹776 Cr, driven by strong volumes in regulated markets and successful USFDA/EU GMP inspections.

Open call summary → Read the filing ↗